Janus Henderson Group’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$764M Sell
4,427,792
-59,157
-1% -$10.2M 0.37% 54
2025
Q1
$694M Buy
4,486,949
+106,567
+2% +$16.5M 0.38% 50
2024
Q4
$603M Buy
4,380,382
+193,688
+5% +$26.7M 0.31% 71
2024
Q3
$625M Buy
4,186,694
+267,881
+7% +$40M 0.32% 70
2024
Q2
$534M Buy
3,918,813
+151,610
+4% +$20.7M 0.29% 83
2024
Q1
$569M Sell
3,767,203
-227,582
-6% -$34.4M 0.31% 78
2023
Q4
$503M Buy
3,994,785
+140,252
+4% +$17.7M 0.3% 85
2023
Q3
$361M Sell
3,854,533
-26,829
-0.7% -$2.51M 0.24% 111
2023
Q2
$346M Buy
3,881,362
+348,532
+10% +$31.1M 0.22% 117
2023
Q1
$379M Sell
3,532,830
-111,125
-3% -$11.9M 0.25% 101
2022
Q4
$445M Sell
3,643,955
-4,029,561
-53% -$492M 0.32% 79
2022
Q3
$792M Buy
7,673,516
+3,812,257
+99% +$394M 0.3% 82
2022
Q2
$359M Buy
3,861,259
+445,732
+13% +$41.4M 0.25% 110
2022
Q1
$401M Buy
3,415,527
+195,562
+6% +$22.9M 0.19% 126
2021
Q4
$433M Sell
3,219,965
-31,702
-1% -$4.26M 0.18% 136
2021
Q3
$518M Buy
3,251,667
+124,496
+4% +$19.8M 0.23% 108
2021
Q2
$411M Sell
3,127,171
-40,141
-1% -$5.28M 0.18% 134
2021
Q1
$408M Buy
3,167,312
+158,483
+5% +$20.4M 0.19% 123
2020
Q4
$502M Buy
3,008,829
+42,223
+1% +$7.04M 0.23% 102
2020
Q3
$458M Buy
2,966,606
+541,918
+22% +$83.6M 0.24% 95
2020
Q2
$359M Buy
2,424,688
+557,498
+30% +$82.5M 0.2% 115
2020
Q1
$210M Buy
1,867,190
+614,186
+49% +$69.2M 0.14% 155
2019
Q4
$174M Buy
1,253,004
+926,762
+284% +$129M 0.09% 249
2019
Q3
$31.4M Buy
+326,242
New +$31.4M 0.02% 717
2017
Q3
Sell
-554,865
Closed -$15.4M 1289
2017
Q2
$15.4M Buy
+554,865
New +$15.4M 0.01% 794